Comparative Analysis of Glaucoma Screening Uptake Among First-Degree Relatives After Community-Based and Hospital-Based Approaches.

Abstract

Glaucoma is the second leading cause of irreversible blindness globally. Primary open-angle glaucoma (POAG) can be genetically transmitted among first-degree relatives (FDRs). Therefore, screening for glaucoma in FDRs can significantly increase the chances of early detection. This study aimed to evaluate the differences in glaucoma screening uptake among FDRs in community and hospital-based settings and the underlying factors, as well as the prevalence of glaucoma in FDRs. Probands and FDRs who underwent screening were classified into two: community-based (group 1) and hospital-based (group 2). They were invited for screening by Village Health Volunteers and ophthalmic nurses, respectively, using information brochures. The FDRs underwent eye examinations, and those with suspected glaucoma underwent further testing for confirmation. The response rates of probands were 261 (38.2%) for group 1 and 196 (48.8%) for group 2. The uptake screening of FDRs was 30.1% and 64.5%, respectively. Multivariate analysis identified that female FDRs {odds ratio [OR]=1.64; 95% CI 1.14-2.38} and those aged above 45 years (OR=2.06; 95% CI 1.32-3.21) were more likely to participate. FDRs residing outside Chanthaburi Province were less likely to attend than those within Chanthaburi (OR=0.36;95% CI 0.22-0.58). FDRs related to probands with blindness were more likely to participate (OR=1.69; 95% CI 1.13-2.54), as were FDRs with secondary school education or higher (OR=2.49;95% CI 1.48-4.18). Those receiving both medical and surgical treatment were more likely to participate (OR=2.22;95% CI 1.51-3.25). The prevalence of glaucoma was 8.3%, and 19.2% of screened FDRs were glaucoma suspects. Group 1 showed a significantly lower screening uptake than Group 2. The factors influencing the uptake of screening by FDRs are gender, age, geographic location, visual acuity of the worse eye in probands, education status of FDRs, and treatment modalities of probands.